AF
NRIX icon

Allworth Financial’s Nurix Therapeutics NRIX Stock Holding History

Allworth Financial’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Buy
879
+734
+506% +$12.5K ﹤0.01% 3143
2026
Q1 		$2.25K Buy
145
+51
+54% +$846 ﹤0.01% 4317
2025
Q4 		$1.78K Buy
94
+10
+12% +$144 ﹤0.01% 4166
2025
Q3 		$777 Buy
+84
New +$872 ﹤0.01% 4319

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Allworth Financial's NRIX Position: Q2 2026 in Review

Allworth Financial increased its Nurix Therapeutics (NRIX) stake by 506% in Q2 2026, buying an estimated $12.5K and bringing the position to 879 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3143.

Allworth Financial first reported a position in NRIX in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Allworth Financial held 879 shares of Nurix Therapeutics worth $21.3K as of Q2 2026.
  • Allworth Financial bought 734 Nurix Therapeutics shares in Q2 2026, an estimated $12.5K.
  • Nurix Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3143 holding.
  • Allworth Financial first reported a position in Nurix Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.